Literature DB >> 15837114

New drugs for tuberculosis: current status and future prospects.

Richard J O'Brien1, Mel Spigelman.   

Abstract

This article reviews two classes of compounds that have advanced into phase II and III clinical trials, long-acting rifamycins and fluoroquinolones, and a number of other drugs that have entered or may enter clinical development in the near future.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15837114     DOI： 10.1016/j.ccm.2005.02.013

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN： 0272-5231            Impact factor:   2.878


  14 in total

1.  Strong in vitro activities of two new rifabutin analogs against multidrug-resistant Mycobacterium tuberculosis.

Authors:  Ana-Belén García; Juan J Palacios; María-Jesús Ruiz; José Barluenga; Fernando Aznar; María-Paz Cabal; José María García; Natalia Díaz
Journal:  Antimicrob Agents Chemother       Date:  2010-09-20       Impact factor: 5.191

Review 2.  New antituberculous drugs in development.

Authors:  Umesh G Lalloo; Anish Ambaram
Journal:  Curr HIV/AIDS Rep       Date:  2010-08       Impact factor: 5.071

3.  Tuberculosis control: challenges of an ancient and ongoing epidemic.

Authors:  Kristin J Cummings
Journal:  Public Health Rep       Date:  2007 Sep-Oct       Impact factor: 2.792

Review 4.  Tuberculosis pharmacotherapy: strategies to optimize patient care.

Authors:  Carole D Mitnick; Bryan McGee; Charles A Peloquin
Journal:  Expert Opin Pharmacother       Date:  2009-02       Impact factor: 3.889

5.  Dry powder nitroimidazopyran antibiotic PA-824 aerosol for inhalation.

Authors:  Jean C Sung; Lucila Garcia-Contreras; Jarod L Verberkmoes; Charles A Peloquin; Katharina J Elbert; Anthony J Hickey; David A Edwards
Journal:  Antimicrob Agents Chemother       Date:  2009-01-12       Impact factor: 5.191

6.  Primary oral tuberculosis.

Authors:  Sankalp Verma; Ravi Prakash Sasankoti Mohan; Udita Singh; Neha Agarwal
Journal:  BMJ Case Rep       Date:  2013-08-01

7.  Dry powder PA-824 aerosols for treatment of tuberculosis in guinea pigs.

Authors:  Lucila Garcia-Contreras; Jean C Sung; Pavan Muttil; Danielle Padilla; Martin Telko; Jarod L Verberkmoes; Katharina J Elbert; Anthony J Hickey; David A Edwards
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

Review 8.  Advances in the diagnosis and treatment of tuberculosis.

Authors:  Payam Nahid; Madhukar Pai; Philip C Hopewell
Journal:  Proc Am Thorac Soc       Date:  2006

9.  Proposed management of childhood tuberculosis in low-incidence countries.

Authors:  Klaus Magdorf; Anne K Detjen
Journal:  Eur J Pediatr       Date:  2008-05-10       Impact factor: 3.183

10.  Multidrug and extensively drug-resistant tuberculosis from a general practice perspective.

Authors:  B M Yashodhara; Choo Beng Huat; Lakshmi Nagappa Naik; Shashikiran Umakanth; Manjunatha Hande; Joseph M Pappachan
Journal:  Infect Drug Resist       Date:  2010-10-22       Impact factor: 4.003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.